Kämmerer Nina, Lemenager Tagrid, Grosshans Martin, Kiefer Falk, Hermann Derik
Klinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut für Seelische Gesundheit, Mannheim.
Psychiatr Prax. 2012 Oct;39(7):351-2. doi: 10.1055/s-0032-1305042. Epub 2012 Jun 11.
Pregabalin is a substance which modulates monoamine release in "hyper-excited" neurons. It binds potently to the α2-δ subunit of calcium channels. Pilotstudies on alcohol- and benzodiazepine dependent patients reported a reduction of withdrawal symptoms through Pregabalin. To our knowledge, no studies have been conducted so far assessing this effect in opiate dependent patients. We report the case of a 43-year-old patient with Pregabalin intake during opiate withdrawal. Multiple inpatient and outpatient detoxifications from maintenance replacement therapy with Buprenorphine in order to reach complete abstinence did not show success because of extended withdrawal symptoms and repeated drug intake. Finally he disrupted his heroine intake with a simultaneously self administration of 300 mg Pregabaline per day and was able to control the withdrawal symptoms. In this time we did control the Pregabalin level in serum and urine in our outpatient clinic. In the course the patient reported that he could treat further relapse with opiate or opioids with Pregabalin successful. This case shows first details for Pregabalin to relief withdrawal symptoms in opiate withdrawal.
普瑞巴林是一种可调节“过度兴奋”神经元中单胺释放的物质。它能强效结合钙通道的α2-δ亚基。对酒精和苯二氮䓬依赖患者的初步研究报告称,普瑞巴林可减轻戒断症状。据我们所知,目前尚未有评估其对阿片类药物依赖患者疗效的研究。我们报告了一例43岁患者在阿片类药物戒断期间服用普瑞巴林的病例。为实现完全戒断,该患者多次住院及门诊接受丁丙诺啡维持替代治疗脱毒,但由于戒断症状持续且反复用药,均未成功。最后,他通过每天自行服用300毫克普瑞巴林中断了海洛因摄入,并能够控制戒断症状。在此期间,我们在门诊对患者血清和尿液中的普瑞巴林水平进行了监测。在此过程中,患者报告称,他可以使用普瑞巴林成功治疗阿片类药物或阿片类物质的进一步复吸情况。该病例首次详细展示了普瑞巴林在缓解阿片类药物戒断症状方面的作用。